Research Labs

Share
and/or
70 Faculty Members found
Memorial Hospital Research Laboratories
Nai-Kong Cheung Lab Group
Nai-Kong V. Cheung, MD, PhD
Physician-scientist Nai-Kong Cheung focuses on engineering antibodies and immune cells to treat both solid tumors and liquid tumors in children.
Human Oncology & Pathogenesis Program
Chi Lab
Ping Chi, MD, PhD
Physician-scientist Ping Chi studies genetic and epigenetic mechanisms of transcriptional regulation by oncogenic factors in GIST, MPNST, melanoma and other solid tumors.
Developmental Biology Program
Junhong Choi, PhD
The Choi Lab develops new synthetic biology tools to study cell-fate decisions in development.
Memorial Hospital Research Laboratories
Jonathan Coleman, MD
Jonathan Coleman is a physician-scientist focused on translational research, cancer genomics, and patient-derived organoid models in the study of urologic malignancies. Ongoing work includes the development of local ablative therapies, their influence on the tumor microenvironment, and implications for therapy response.
Memorial Hospital Research Laboratories
Aimee Crago, MD, PhD
Physician-scientist Aimee Crago studies mechanisms by which common genomic events drive initiation and progression of soft tissue tumors.
Chemical Biology Program
The Yael David Lab
Yael David, PhD
Yael David’s lab develops and applies methods in chemical biology toward studying epigenetic regulation and its correlation with disease states.
Memorial Hospital Research Laboratories
The Luis Diaz Lab
Luis Diaz Jr., MD
Our team is focused on developing novel tools and approaches for the diagnosis and treatment of cancer using genomics as a guide.
Human Oncology & Pathogenesis Program
Kojo S. Elenitoba-Johnson, MD
My research involves the elucidation of genetic and biologic insights of human malignant lymphomas. We leverage large-scale unbiased profiling including genomics, transcriptomics, proteomics to identify candidate oncogenes and proteins that are pathogenetically relevant in lymphoma. We utilize molecular technologies, human tumor tissues and patient-derived xenografts and transgenic animal models to determine the functional significance of novel genes and proteins involved in lymphoma pathogenesis. Using primary tumors as our discovery models, the overall goal of our studies is to understand novel mechanisms of oncogenesis, identify tumor biomarkers and vulnerabilities that will facilitate early detection and precision therapies that improve patient outcomes.
Human Oncology & Pathogenesis Program
The James Fagin Lab
James A. Fagin, MD
Physician-scientist James Fagin focuses on the pathogenesis of thyroid cancer and the role of oncogenic kinases.
Molecular Pharmacology Program
The Karuna Ganesh Lab
Karuna Ganesh, MD, PhD
Physician-scientist Karuna Ganesh studies stem cell plasticity in metastasis, therapy resistance and tissue regeneration.